HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful living donor liver transplantation of fulminant liver failure due to isoniazid prophylaxis.

Abstract
Progressive liver failure is rarely seen in tuberculosis chemoprophylaxis with isoniazid. We present a case of a 32-year-old woman admitted to our clinic reporting abdominal pain, nausea and vomiting for 2 days. The initial diagnosis was fulminant toxic hepatitis due to isoniazid chemoprophylaxis, which was treated successfully with living donor transplantation. Tuberculosis continues to be a significant public health problem. Isoniazid-related hepatotoxicity is extremely rare in adults. The only treatment in cases of fulminant liver failure is orthotopic liver transplantation from a deceased or living donor. If a deceased donor is not available or the patient refuses this treatment, living donor transplantation is the only choice. Although rare, isoniazid used as protective therapy for pulmonary tuberculosis can lead to fulminant liver failure. When cadaveric liver transplantation is not available, living donor liver transplantation is vital.
AuthorsTuğrul Çakır, Cengiz Ara, Hacı Vural Soyer, Suleyman Koc
JournalBMJ case reports (BMJ Case Rep) Vol. 2015 (Jun 23 2015) ISSN: 1757-790X [Electronic] England
PMID26106175 (Publication Type: Case Reports, Journal Article)
Copyright2015 BMJ Publishing Group Ltd.
Chemical References
  • Antitubercular Agents
  • Isoniazid
Topics
  • Adult
  • Antitubercular Agents (adverse effects, therapeutic use)
  • Female
  • Humans
  • Isoniazid (adverse effects, therapeutic use)
  • Liver Failure, Acute (chemically induced, surgery)
  • Liver Transplantation
  • Living Donors
  • Tuberculosis (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: